BUSINESS

• Nucala Filed in Japan for Chronic Rhinosinusitis with Nasal Polyps: GSK
  September 5, 2023

• Santen to Run Voluntary Redundancy Program Targeting Age 50 and Up
  September 5, 2023

• Otsuka to Acquire Canada’s Psychedelic Specialist Mindset Pharma
  September 4, 2023

• Enhertu Gets 2 More Breakthrough Therapy Tags in US: Daiichi Sankyo
  September 4, 2023

• Shionogi Wins SCARDA R&D Funding for Nasal Vaccines for Flu, COVID
  September 1, 2023

• Atozet Generic to Hit Japan Shelves on Sept. 1
  September 1, 2023

• Ono, Twist Bio Tie Up on Antibody Discovery for Autoimmune Disorders
  September 1, 2023

• 2 Amyloid PET Imaging Agents Expand Labels as Lecanemab Approval Nears
  September 1, 2023

• Sobi’s PNH Drug to Hit Japan Market on Sept. 4, Taiho's FGFR Inhibitor on Sept. 7
  August 31, 2023

• Novartis Rolls Out Luxturna in Japan, 2 Treatment Facilities Selected
  August 31, 2023

• Sandoz Completes Acquisition of Astellas’ Antifungal Mycamine
  August 31, 2023

• Toray to Kick Off Antibody PII Studies for Gastric Cancer
  August 31, 2023

• Takeda Snags Japan Rights to ImmunoGen’s ADC
  August 30, 2023

• Shionogi Rolls Out Flomox Fine Granules for Children in China
  August 30, 2023

• First 10 Drugs Named for Medicare Price Negotiations, None from Japan Firms
  August 30, 2023

• Oral Flu Drug Prescriptions 11 Times More than Pre-COVID: July Survey
  August 29, 2023

• Nichi-Iko Winds Up Avastin Biosimilar Deal with Sandoz
  August 29, 2023

• Pfizer Gets Breast, Ovarian Cancer Nod for Avastin Biosimilar
  August 29, 2023

• Taiho Gets Options to French Firm’s GnT-V-Targeted Cancer Drug in Asia
  August 28, 2023

• FDA Grants Priority Review for Xtandi in Earlier Type of Prostate Cancer
  August 25, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 132
• 133
• 134
• 135
• 136
• 137
• 138
• 139
• 140
• …
• Next ›
• 最終 »